Original Source(s)
Related Content
Roswell Park Launches Exclusive Phase 1 Clinical Trial of ‘Armored’ CAR T-Cell Therapy for Ovarian Cancer
Roswell Park Comprehensive Cancer Center is currently recruiting for a phase 1 clinical trial of the new therapy (NCT07489287), called GB-5267, which was co-developed by Roswell Park and the therapeutics company Generate:Biomedicines.
June 24, 2026
-
3 min
How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages
“There is incredible uncertainty in drug dosing.”
by Arthur Allen
August 20, 2026
-
15 min
10 Growing US Metro Areas to Consider for Private Practice
These 10 metropolitan areas recorded population growth and had recently completed, ongoing, or announced health care infrastructure projects.
September 1, 2026
-
5 min
